Neratinib is effective in breast tumors bearing both...

Science Signaling 2018 / 10 Vol. 11; Iss. 551

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

Cocco, Emiliano, Javier Carmona, F., Razavi, Pedram, Won, Helen H., Cai, Yanyan, Rossi, Valentina, Chan, Carmen, Cownie, James, Soong, Joanne, Toska, Eneda, Shifman, Sophie G., Sarotto, Ivana, Savas,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Science Signaling
DOI:
10.1126/scisignal.aat9773
Date:
October, 2018
File:
PDF, 2.08 MB
english, 2018
Conversion to is in progress
Conversion to is failed